Versigent (NYSE:VGNT) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Versigent (NYSE:VGNT) have been given an average recommendation of “Moderate Buy” by the eleven analysts that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $47.3333.

A number of brokerages recently weighed in on VGNT. TD Cowen raised their target price on shares of Versigent from $47.00 to $49.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $38.00 price target on shares of Versigent in a report on Thursday, May 7th. Wolfe Research began coverage on Versigent in a research report on Thursday, April 30th. They set an “outperform” rating and a $53.00 target price on the stock. Royal Bank Of Canada started coverage on Versigent in a report on Tuesday, March 31st. They set a “sector perform” rating and a $28.00 target price for the company. Finally, Evercore reiterated an “outperform” rating and issued a $60.00 price target on shares of Versigent in a research report on Monday, May 18th.

Versigent Price Performance

NYSE:VGNT opened at $41.73 on Thursday. Versigent has a twelve month low of $26.34 and a twelve month high of $50.88. The firm’s 50-day simple moving average is $42.56.

Versigent (NYSE:VGNT) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $999.00 earnings per share (EPS) for the quarter.